PharmaShots | Incisive News in 3 Shots

Subscribe Now

Inlyta

Merck's Keytruda (pembrolizumab) in Combination with Inlyta (axitinib) Receives European Commission's Approval as a 1L Therapy for Advanced Renal Cell Carcinoma

Merck's Keytruda (pembrolizumab) in Combination with Inlyta (axitinib) Receives European Commission's Approval as a 1L Therapy for...

September 4, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us